Eidos Therapeutics, Inc. EPS - Earnings per Share 2018-2020 | EIDX
Eidos Therapeutics, Inc. eps - earnings per share from 2018 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Eidos Therapeutics, Inc. Annual EPS |
| 2019 |
$-1.03 |
| 2018 |
$-1.86 |
| 2017 |
$-3.32 |
| 2016 |
$-0.98 |
| Eidos Therapeutics, Inc. Quarterly EPS |
| 2020-09-30 |
$-0.79 |
| 2020-06-30 |
$-0.75 |
| 2020-03-31 |
$-0.60 |
| 2019-12-31 |
$-0.50 |
| 2019-09-30 |
$0.18 |
| 2019-06-30 |
$-0.39 |
| 2019-03-31 |
$-0.32 |
| 2018-12-31 |
$1.65 |
| 2018-09-30 |
$-0.30 |
| 2018-06-30 |
$-1.40 |
| 2018-03-31 |
$-1.81 |
| 2017-12-31 |
$-1.37 |
| 2017-09-30 |
$-0.74 |
| 2017-06-30 |
$-0.49 |
| 2017-03-31 |
$-0.72 |
